You just read:

Prosonix' Marketing Authorisation Application for PSX1001 - a Generic Version of GlaxoSmithKline's Flixotide® Evohaler® - Under Assessment in EU

News provided by

Prosonix

02 Sep, 2014, 09:00 BST